EdgarLookup

NEUROONE MEDICAL TECHNOLOGIES Corp — All Filings

619 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-KT/A 10-Q 10-Q/A 144 3 3/A 4 4/A 424B3 424B5 8-A12B 8-A12G 8-K 8-K/A ARS CERT CORRESP CT ORDER D D/A DEF 14A DEF 14C DEFA14A DEL AM EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PRER14A PRER14C S-1 S-1/A S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13G SCHEDULE 13G/A SD UPLOAD
Form Description Accession Number Filed Period
4 PRIMARY DOCUMENT 0001709738-25-000006 May 23, 2025 May 21, 2025
4 PRIMARY DOCUMENT 0001709738-25-000005 May 21, 2025 May 19, 2025
SCHEDULE 13G/A 0000935836-25-000373 May 15, 2025
10-Q QUARTERLY REPORT 0001213900-25-042266 May 13, 2025 Mar 31, 2025
8-K CURRENT REPORT 0001213900-25-042270 May 13, 2025
8-K CURRENT REPORT 0001213900-25-041554 May 9, 2025 May 6, 2025
SCHEDULE 13G/A 0001535264-25-000040 May 9, 2025
4 PRIMARY DOCUMENT 0001837830-25-000002 Apr 21, 2025 Apr 17, 2025
4 PRIMARY DOCUMENT 0002000429-25-000001 Apr 21, 2025 Apr 17, 2025
4 PRIMARY DOCUMENT 0001772652-25-000004 Apr 21, 2025 Apr 17, 2025
4 PRIMARY DOCUMENT 0001709738-25-000004 Apr 21, 2025 Apr 17, 2025
4 PRIMARY DOCUMENT 0001540354-25-000005 Apr 21, 2025 Apr 17, 2025
4 PRIMARY DOCUMENT 0001837830-25-000001 Apr 7, 2025 Apr 4, 2025
4 PRIMARY DOCUMENT 0001540354-25-000004 Apr 7, 2025 Apr 4, 2025
8-K CURRENT REPORT 0001213900-25-029442 Apr 7, 2025 Apr 4, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-028999 Apr 4, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-028610 Apr 3, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-028612 Apr 3, 2025
4 PRIMARY DOCUMENT 0001709738-25-000003 Apr 2, 2025 Mar 31, 2025
4 PRIMARY DOCUMENT 0001772652-25-000003 Apr 2, 2025 Mar 31, 2025
4 PRIMARY DOCUMENT 0001540354-25-000003 Apr 2, 2025 Mar 31, 2025
144 0001973097-25-000002 Mar 14, 2025
S-8 REGISTRATION STATEMENT 0001213900-25-016107 Feb 21, 2025
4 PRIMARY DOCUMENT 0001540354-25-000002 Feb 20, 2025 Feb 18, 2025
4 PRIMARY DOCUMENT 0001709738-25-000002 Feb 20, 2025 Feb 18, 2025
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-25-015683 Feb 20, 2025 Feb 14, 2025
4 PRIMARY DOCUMENT 0001772652-25-000002 Feb 20, 2025 Feb 18, 2025
4 PRIMARY DOCUMENT 0001215243-25-000001 Feb 19, 2025 Feb 14, 2025
4 0001213900-25-015155 Feb 19, 2025 Feb 14, 2025
4 PRIMARY DOCUMENT 0001656026-25-000001 Feb 19, 2025 Feb 14, 2025
8-K CURRENT REPORT 0001213900-25-014281 Feb 14, 2025
SCHEDULE 13G/A 0000919574-25-001497 Feb 14, 2025
8-K CURRENT REPORT 0001213900-25-012510 Feb 12, 2025
10-Q QUARTERLY REPORT 0001213900-25-012511 Feb 12, 2025 Dec 31, 2024
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-011304 Feb 7, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-010537 Feb 5, 2025
8-K CURRENT REPORT 0001213900-25-010083 Feb 4, 2025 Feb 3, 2025
4 PRIMARY DOCUMENT 0001540354-25-000001 Feb 4, 2025 Jan 31, 2025
SCHEDULE 13G/A 0001737260-25-000003 Feb 4, 2025
4 PRIMARY DOCUMENT 0001709738-25-000001 Feb 4, 2025 Jan 31, 2025
4 PRIMARY DOCUMENT 0001772652-25-000001 Feb 4, 2025 Jan 31, 2025
DEF 14A PROXY STATEMENT 0001213900-25-005016 Jan 21, 2025 Feb 14, 2025
ARS FORM ARS 0001213900-25-005024 Jan 21, 2025 Sep 30, 2024
8-K CURRENT REPORT 0001213900-25-003166 Jan 14, 2025
PRER14A REVISED PRELIMINARY PROXY STATEMENT 0001213900-25-003041 Jan 13, 2025
8-K CURRENT REPORT 0001213900-25-002381 Jan 10, 2025
PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-25-002689 Jan 10, 2025
8-K CURRENT REPORT 0001213900-25-002728 Jan 10, 2025 Jan 8, 2025
4 0001213900-25-000720 Jan 3, 2025 Dec 31, 2024
4 0001213900-25-000717 Jan 3, 2025 Dec 31, 2024